99% Savings - Buy Just @1 Rs X
Arvast F is a prescription medicine that is available as a Tablet. Arvast F also has some secondary and off-label uses. These are listed below.
The right dosage of Arvast F depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Arvast F include Nausea or vomiting, Headache, Constipation. While these are the most often observed Arvast F side effects, there are can be others also. These have been listed below. These side effects of Arvast F are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Arvast F's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Arvast F's effects on the liver, heart and kidney, if any, have been listed below.
Arvast F is contraindicated in people with pre-existing medical conditions like Diabetes as it can result in adverse effects.
Besides this, Arvast F may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Arvast F is considered not safe while driving, and is not addictive.
Arvast F is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Arvast F safe for pregnant women?
Arvast F may have some side effects during pregnancy. Pregnant women should discontinue the use of Arvast F, and talk to their doctor, if they notice any discomfort.
Is the use of Arvast F safe during breastfeeding?
Arvast F can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Arvast F on the Kidneys?
Arvast F has very mild side effects on the kidneys.
What is the effect of Arvast F on the Liver?
Very few cases of side effects of Arvast F on the liver have been reported.
What is the effect of Arvast F on the Heart?
The heart can be affected by Arvast F. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Arvast F should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Arvast F unless your doctor advises you to do so -
Is this Arvast F habit forming or addictive?
No, there is no any evidence that Arvast F is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Arvast F, you should not drive or work on any heavy machine, as Arvast F can make you drowsy.
Is it safe?
Arvast F is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Arvast F cannot treat any kind of mental disorder.
Interaction between Food and Arvast F
Due to a lack of research, nothing can be said about the consequences of taking Arvast F together with food.
Interaction between Alcohol and Arvast F
Information about the interaction of Arvast F and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650